{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:11:26Z","timestamp":1791598286487,"version":"4.3.4"},"reference-count":41,"publisher":"PeerJ","license":[{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome (PCOS) is a disorder in reproductive age women and is characterized by hyperandrogenic anovulation and oligo-amenorrhea, which leads to infertility. Anovulation in PCOS is associated with low follicle-stimulating hormone levels and the arrest of antral follicle development in the final stages of maturation. L-carnitine (LC) plays a role in fatty acid metabolism, which is found to be lacking in PCOS patients. This systematic review and meta-analysis aimed to determine the effectiveness of LC supplementation for patients with PCOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Psychological Information Database (PsycINFO), and the World Health Organization International Clinical Trials Registry Platform for all randomized control trials, comparing LC alone or in combination with other standard treatments for the treatment of PCOS from inception till June 2021. We independently screened titles and abstracts to identify available trials, and complete texts of the trials were checked for eligibility. Data on the methods, interventions, outcomes, and risk of bias from the included trials were independently extracted by the authors. The estimation of risk ratios and mean differences with a 95 percent confidence interval (CI) was performed using a random-effects model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Nine studies with 995 participants were included in this review. Five comparison groups were involved. In one comparison group, LC reduced the fasting plasma glucose (FPG) (mean differences (MD) \u22125.10, 95% CI [\u22126.25 to \u22123.95];\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.00001), serum low-density lipoprotein (LDL) (MD \u221225.00, 95% CI [\u221227.93 to \u221222.07];\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.00001), serum total cholesterol (MD \u221221.00, 95% CI [\u221224.14 to \u221217.86];\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.00001), and serum triglyceride (TG) (MD \u22129.00, 95% CI [\u221211.46 to \u22126.54];\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.00001) with moderate certainty of evidence. Another comparison group demonstrated that LC lowers the LDL (MD \u221212.00, 95% CI [\u221215.80 to \u22128.20];\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.00001), serum total cholesterol (MD \u221224.00, 95% CI [\u221227.61 to \u221220.39];\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.00001), and serum TG (MD \u221219.00, 95% CI [\u221222.79 to \u221215.21];\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.00001) with moderate certainty of evidence.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>There was low to moderate certainty of evidence that LC improves Body Mass Index (BMI) and serum LDL, TG, and total cholesterol levels in women with PCOS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.7717\/peerj.13992","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T05:14:21Z","timestamp":1663305261000},"page":"e13992","source":"Crossref","is-referenced-by-count":12,"title":["Effects of L-carnitine supplementation for women with polycystic ovary syndrome: a systematic review and meta-analysis"],"prefix":"10.7717","volume":"10","author":[{"given":"Mohd Falihin","family":"Mohd Shukri","sequence":"first","affiliation":[{"name":"Department of Family Medicine, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Noor","family":"Norhayati","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salziyan","family":"Badrin","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azidah","family":"Abdul Kadir","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4443","published-online":{"date-parts":[[2022,9,16]]},"reference":[{"key":"10.7717\/peerj.13992\/ref-1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/IJWH.S11304","article-title":"Treatment options for polycystic ovary syndrome","volume":"3","author":"Badawy","year":"2011","journal-title":"International Journal of Women\u2019s Health"},{"key":"10.7717\/peerj.13992\/ref-2","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1080\/01443615.2016.1264375","article-title":"Plasma L-carnitine levels of obese and non-obese polycystic ovary syndrome patients","volume":"37","author":"Celik","year":"2017","journal-title":"Journal of Obstetrics and Gynaecology"},{"key":"10.7717\/peerj.13992\/ref-3","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.cca.2019.11.016","article-title":"Metabolic alterations associated with polycystic ovary syndrome: a UPLC Q-exactive based metabolomic study","volume":"502","author":"Chen","year":"2020","journal-title":"Clinica Chimica Acta"},{"key":"10.7717\/peerj.13992\/ref-4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jpba.2016.01.025","article-title":"UHPLC\/Q-TOFMS-based plasma metabolomics of polycystic ovary syndrome patients with and without insulin resistance","volume":"121","author":"Chen","year":"2016","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"10.7717\/peerj.13992\/ref-5","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.fertnstert.2018.08.021","article-title":"Beyond fertility: polycystic ovary syndrome and long-term health","volume":"110","author":"Cooney","year":"2018","journal-title":"Fertility and Sterility"},{"key":"10.7717\/peerj.13992\/ref-6","doi-asserted-by":"publisher","first-page":"E707-E718","DOI":"10.1152\/ajpendo.00532.2018","article-title":"Amino acid and fatty acid metabolomic profile during fasting and hyperinsulinemia in girls with polycystic ovarian syndrome","volume":"316","author":"Cree-Green","year":"2019","journal-title":"American Journal of Physiology-Endocrinology and Metabolism"},{"key":"10.7717\/peerj.13992\/ref-7","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1080\/13543784.2020.1781815","article-title":"Current and experimental drug therapy for the treatment of polycystic ovarian syndrome","volume":"29","author":"Della Corte","year":"2020","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10.7717\/peerj.13992\/ref-8","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.1007\/s00216-015-8670-x","article-title":"Serum metabolomics study of polycystic ovary syndrome based on UPLC-QTOF-MS coupled with a pattern recognition approach","volume":"407","author":"Dong","year":"2015","journal-title":"Analytical and Bioanalytical Chemistry"},{"key":"10.7717\/peerj.13992\/ref-9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/ijgo.12902","article-title":"Randomized controlled trial of N-acetylcysteine versus l-carnitine among women with clomiphene-citrate-resistant polycystic ovary syndrome","volume":"147","author":"El Sharkwy","year":"2019","journal-title":"International Journal of Gynecology & Obstetrics"},{"key":"10.7717\/peerj.13992\/ref-10","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1080\/09513590.2019.1576622","article-title":"l-Carnitine plus metformin in clomiphene-resistant obese PCOS women, reproductive and metabolic effects: a randomized clinical trial","volume":"35","author":"El Sharkwy","year":"2019","journal-title":"Gynecological Endocrinology"},{"key":"10.7717\/peerj.13992\/ref-11","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1111\/cen.14101","article-title":"Circulating gut microbiota metabolite trimethylamine N-oxide and oral contraceptive use in polycystic ovary syndrome","volume":"91","author":"Eyupoglu","year":"2019","journal-title":"Clinical Endocrinology"},{"key":"10.7717\/peerj.13992\/ref-12","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/humrep\/den109","article-title":"Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome","volume":"23","author":"Fenkci","year":"2008","journal-title":"Human Reproduction"},{"key":"10.7717\/peerj.13992\/ref-13","article-title":"GRADEpro Guideline Development Tool [Software] McMaster University and Evidence Prime","author":"GDT","year":"2022"},{"key":"10.7717\/peerj.13992\/ref-14","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","article-title":"What is quality of evidence and why is it important to clinicians?","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.7717\/peerj.13992\/ref-15","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1586\/17512433.2016.1160777","article-title":"The effect of epilepsy and antiepileptic drugs on sexual, reproductive and gonadal health of adults with epilepsy","volume":"9","author":"Hamed","year":"2016","journal-title":"Expert Review of Clinical Pharmacology"},{"key":"10.7717\/peerj.13992\/ref-16","article-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated 2021)","author":"Higgins","year":"2021"},{"key":"10.7717\/peerj.13992\/ref-17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ejogrb.2014.06.008","article-title":"Adding L-carnitine to clomiphene resistant PCOS women improves the quality of ovulation and the pregnancy rate. A randomized clinical trial","volume":"180","author":"Ismail","year":"2014","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"key":"10.7717\/peerj.13992\/ref-18","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1080\/09513590.2017.1290071","article-title":"Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial","volume":"33","author":"Jamilian","year":"2017","journal-title":"Gynecological Endocrinology"},{"key":"10.7717\/peerj.13992\/ref-19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/0167482X.2018.1557144","article-title":"Carnitine and chromium co-supplementation affects mental health, hormonal, inflammatory, genetic, and oxidative stress parameters in women with polycystic ovary syndrome","author":"Jamilian","year":"2019","journal-title":"Journal of Psychosomatic Obstetrics and Gynaecology"},{"key":"10.7717\/peerj.13992\/ref-20","doi-asserted-by":"publisher","DOI":"10.1007\/s12011-019-01720-8","article-title":"Effects of chromium and carnitine co-supplementation on body weight and metabolic profiles in overweight and obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial","author":"Jamilian","year":"2019","journal-title":"Biological Trace Element Research"},{"key":"10.7717\/peerj.13992\/ref-21","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/mrd.23104","article-title":"Serum metabolomics analysis of patients with polycystic ovary syndrome by mass spectrometry","volume":"86","author":"Jia","year":"2019","journal-title":"Molecular Reproduction and Development"},{"key":"10.7717\/peerj.13992\/ref-22","doi-asserted-by":"publisher","first-page":"P808","DOI":"10.1016\/j.numecd.2014.03.007","article-title":"Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: evidence and controversies","volume":"24","author":"Johri","year":"2014","journal-title":"Nutrition, Metabolism, and Cardiovascular Diseases: NMCD"},{"key":"10.7717\/peerj.13992\/ref-23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.bbacli.2016.04.003","article-title":"Changes in plasma metabolites and glucose homeostasis during omega-3 polyunsaturated fatty acid supplementation in women with polycystic ovary syndrome","volume":"5","author":"Karakas","year":"2016","journal-title":"BBA Clinical"},{"key":"10.7717\/peerj.13992\/ref-24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21608\/ebwhj.2019.17527.1032","article-title":"L-Carnitine and clomiphene citrate for induction of ovulation in women with polycystic ovary syndrome: randomized controlled trial","volume":"10","author":"Kortam","year":"2020","journal-title":"Evidence Based Women\u2019s Health Journal"},{"key":"10.7717\/peerj.13992\/ref-25","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1080\/09513590.2019.1576616","article-title":"Potential roles of carnitine in patients with polycystic ovary syndrome: a systematic review","volume":"35","author":"Maleki","year":"2019","journal-title":"Gynecological Endocrinology"},{"key":"10.7717\/peerj.13992\/ref-26","volume-title":"Revman Manager","author":"Manager","year":"2020","edition":"5"},{"key":"10.7717\/peerj.13992\/ref-27","article-title":"Effects of triple drug cocktail therapy on metabolic, endocrine alterations and perceived stress in patients with PCOS","author":"Nct","year":"2019"},{"key":"10.7717\/peerj.13992\/ref-28","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/s0140-6736(07)61345-2","article-title":"Polycystic ovary syndrome","volume":"370","author":"Norman","year":"2007","journal-title":"Lancet"},{"key":"10.7717\/peerj.13992\/ref-29","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ando.2014.07.111","article-title":"Long term complications of polycystic ovary syndrome (PCOS)","volume":"75","author":"Peign\u00e9","year":"2014","journal-title":"Annales d\u2019Endocrinologie"},{"key":"10.7717\/peerj.13992\/ref-30","doi-asserted-by":"publisher","first-page":"392","DOI":"10.5935\/1518-0557.20190033","article-title":"Effects of L-carnitine on polycystic ovary syndrome","volume":"23","author":"Salehpour","year":"2019","journal-title":"JBRA Assisted Reproduction"},{"key":"10.7717\/peerj.13992\/ref-31","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/cen.13003","article-title":"Oral carnitine supplementation reduces body weight and insulin resistance in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial","volume":"84","author":"Samimi","year":"2016","journal-title":"Clinical Endocrinology"},{"key":"10.7717\/peerj.13992\/ref-32","doi-asserted-by":"publisher","first-page":"e13097","DOI":"10.14814\/phy2.13097","article-title":"Metabolic profiling reveals reprogramming of lipid metabolic pathways in treatment of polycystic ovary syndrome with 3-iodothyronamine","volume":"5","author":"Selen Alpergin","year":"2017","journal-title":"Physiological Reports"},{"key":"10.7717\/peerj.13992\/ref-33","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2021.1878135","article-title":"The effect of adding L-Carnitine to the GnRH-antagonist protocol on assisted reproductive technology outcome in women with polycystic ovarian syndrome: a randomized clinical trial","author":"Sheida","year":"2021","journal-title":"Gynecological Endocrinology"},{"key":"10.7717\/peerj.13992\/ref-34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/CLEP.S37559","article-title":"Epidemiology, diagnosis, and management of polycystic ovary syndrome","volume":"6","author":"Sirmans","year":"2013","journal-title":"Clinical Epidemiology"},{"issue":"8","key":"10.7717\/peerj.13992\/ref-35","first-page":"469","article-title":"Effect of addition of L-Carnitine in Polycystic Ovary Syndrome (PCOS) patients with clomiphene citrate and gonodotropin resistant","volume":"3","author":"Latifian","year":"2015","journal-title":"International Journal of Current Research and Academic Review"},{"key":"10.7717\/peerj.13992\/ref-36","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12958-019-0490-y","article-title":"Identification of potential metabolic biomarkers of polycystic ovary syndrome in follicular fluid by SWATH mass spectrometry","volume":"17","author":"Sun","year":"2019","journal-title":"Reproductive Biology and Endocrinology"},{"key":"10.7717\/peerj.13992\/ref-37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/ijpvm.IJPVM_2_18","article-title":"Effects of carnitine administration on carotid intima-media thickness and inflammatory factors in patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial","volume":"10","author":"Talari","year":"2019","journal-title":"International Journal of Preventive Medicine"},{"key":"10.7717\/peerj.13992\/ref-38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4239\/wjd.v2.i3.33","article-title":"Assessing and treating insulin resistance in women with polycystic ovarian syndrome","volume":"2","author":"Traub","year":"2011","journal-title":"World Journal of Diabetes"},{"key":"10.7717\/peerj.13992\/ref-39","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1016\/j.fertnstert.2012.08.024","article-title":"Free carnitine and acylcarnitines in obese patients with polycystic ovary syndrome and effects of pioglitazone treatment","volume":"98","author":"Vigerust","year":"2012","journal-title":"Fertility and Sterility"},{"key":"10.7717\/peerj.13992\/ref-40","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1080\/00365513.2019.1658215","article-title":"Lipidomics biomarkers in women with polycystic ovary syndrome (PCOS) using ultra-high performance liquid chromatography-quadrupole time of flight electrospray in a positive ionization mode mass spectrometry","volume":"79","author":"Vonica","year":"2019","journal-title":"Scandinavian Journal of Clinical and Laboratory Investigation"},{"key":"10.7717\/peerj.13992\/ref-41","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.freeradbiomed.2015.05.013","article-title":"Metabolism alteration in follicular niche: the nexus among intermediary metabolism, mitochondrial function, and classic polycystic ovary syndrome","volume":"86","author":"Zhao","year":"2015","journal-title":"Free Radical Biology and Medicine"}],"container-title":["PeerJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/peerj.com\/articles\/13992.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/13992.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/13992.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/13992.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T05:14:31Z","timestamp":1663305271000},"score":1,"resource":{"primary":{"URL":"https:\/\/peerj.com\/articles\/13992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":41,"alternative-id":["10.7717\/peerj.13992"],"URL":"https:\/\/doi.org\/10.7717\/peerj.13992","archive":["CLOCKSS","LOCKSS","Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.7287\/peerj.13992v0.2\/reviews\/2","asserted-by":"object"},{"id-type":"doi","id":"10.7287\/peerj.13992v0.1\/reviews\/3","asserted-by":"object"},{"id-type":"doi","id":"10.7287\/peerj.13992v0.1\/reviews\/2","asserted-by":"object"},{"id-type":"doi","id":"10.7287\/peerj.13992v0.1\/reviews\/1","asserted-by":"object"}]},"ISSN":["2167-8359"],"issn-type":[{"value":"2167-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,16]]},"article-number":"e13992"}}